Chief Medical and Scientific Officer
Dr. W. Michael Korn is Biocartis’ Chief Medical and Scientific Officer since August 12, 2024. Dr. Korn brings extensive experience in oncology research and practice to the company and has published close to 120 peer-reviewed scientific articles. Prior to joining Biocartis, Dr. Korn served as Chief Medical Officer at Invitae Corporation where he focused on broadening the indications for genetic testing and led the development of novel clinical studies of an advanced MRD assay. Dr. Korn also served as Chief Medical Officer at Caris Life Sciences where he was instrumental in developing AI-driven molecular signatures and advancing clinical and translational research in precision oncology. Dr. Korn is a faculty (volunteer) at the University of California San Francisco (UCSF) in the Division of Hematology/Oncology. Dr. Korn holds an MD from the Heinrich Heine University of Düsseldorf. He completed his internal medicine and medical oncology training at the West German Cancer Center in Essen, Germany. He is board certified in internal medicine and medical oncology.
